We hypothesized that the others EGFR-positive KRAS mutant cancers were affected similar with EGFR-positive KRAS mutant lung cancers treated with R9VH36 and might reveal the different mechanism between the R9VH36 and EGFR-TKI. This evidence concerns the gene EGFR and lung cancer.